Growth Metrics

Alector (ALEC) Non-Current Deffered Revenue (2018 - 2026)

Alector (ALEC) reported Non-Current Deffered Revenue of $162.9 million for Q1 2026, down 4.37% year-over-year from $170.3 million in Q1 2025, and down 1.02% on a QoQ basis from $164.5 million in Q4 2025.

Alector (ALEC) has 9 years of Non-Current Deffered Revenue data on file, last reported at $162.9 million in Q1 2026.

  • Quarterly Non-Current Deffered Revenue fell 4.37% year-over-year to $162.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162.9 million (down 4.37% YoY) and the FY2025 annual result came in at $164.5 million, down 4.43% from the prior year.
  • Non-Current Deffered Revenue eased to $162.9 million in Q1 2026 per ALEC's latest filing, from $164.5 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $505.1 million in Q1 2022 and bottomed at $162.9 million in Q1 2026.
  • The 5-year median for Non-Current Deffered Revenue is $204.6 million (2024), against an average of $262.9 million.
  • The widest annual swing landed in 2022, when Non-Current Deffered Revenue surged 378.83%; it then plunged 52.54% in 2024.
  • Tracing ALEC's Non-Current Deffered Revenue over 5 years: stood at $443.4 million in 2022, then tumbled by 52.44% to $210.8 million in 2023, then dropped by 18.34% to $172.2 million in 2024, then dropped by 4.43% to $164.5 million in 2025, then retreated by 1.02% to $162.9 million in 2026.
  • Per Business Quant, the three latest ALEC Non-Current Deffered Revenue figures stand at $162.9 million (Q1 2026), $164.5 million (Q4 2025), and $167.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Alector 238.87 Mn 32.36 Mn - 162.87 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 162.87 Mn
Dec 31, 2025 164.54 Mn
Sep 30, 2025 167.27 Mn
Jun 30, 2025 168.87 Mn
Mar 31, 2025 170.31 Mn
Dec 31, 2024 172.17 Mn
Sep 30, 2024 192.78 Mn
Jun 30, 2024 199.58 Mn
Mar 31, 2024 204.58 Mn
Dec 31, 2023 210.85 Mn
Sep 30, 2023 229.85 Mn
Jun 30, 2023 245.34 Mn
Mar 31, 2023 431.08 Mn
Dec 31, 2022 443.37 Mn
Sep 30, 2022 386.36 Mn
Jun 30, 2022 413.90 Mn
Mar 31, 2022 505.13 Mn
Dec 31, 2021 334.42 Mn
Sep 30, 2021 344.53 Mn
Jun 30, 2021 96.21 Mn
Mar 31, 2021 105.49 Mn
Dec 31, 2020 108.42 Mn
Sep 30, 2020 110.56 Mn
Jun 30, 2020 110.32 Mn
Mar 31, 2020 114.14 Mn
Dec 31, 2019 123.24 Mn
Sep 30, 2019 129.88 Mn
Jun 30, 2019 121.23 Mn
Mar 31, 2019 130.49 Mn
Dec 31, 2018 139.72 Mn